Suven Pharmaceuticals LimitedWhat company does?Suven Pharmaceuticals Limited is a pharmaceutical research and development company.
Established1989
Entity typePrivate
HeadquartersIndia
SegmentB2B,B2C
Suven Pharmaceuticals Limited is a share market listed company
in the Healthcare industry
.
It got listed on NSE on 09-MAR-2020 under the trading symbol SUVENPHAR.
On BSE it is listed under trading symbol SUVENPHAR.
The company operates in
Pharmaceuticals
,
Healthcare
and
Biotechnology
categories.
Check suvenphar stock details.
About Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited is a global, vertically integrated pharmaceutical company that specializes in developing and commercializing innovative products for central nervous system (CNS) disorders. The company's research and development efforts are focused on discovering new drugs to treat conditions such as Alzheimer’s disease, schizophrenia, depression, Parkinson’s disease, and other neurological disorders.
's use of advanced technologies like structure-based drug design (SBDD), computer-aided drug design (CADD), and high-throughput screening (HTS) underscores their dedication towards pioneering discoveries.
In recent years, has expanded international collaborations which include licensing agreements with major Pharma companies for co-development programs involving novel chemical entities targeted at special therapeutic areas.
Founded in 1989 by Venkat Jasti, Suven has become a leading player in the CNS segment with its extensive portfolio of over 330 granted patents across various countries including USA, Europe & Japan.
The company offers contract research services to global pharma companies through its state-of-the-art research facilities located in India. Suven's diverse product pipeline includes promising drug candidates at different stages of clinical development targeting various neurotransmitter receptors. One of the key factors that sets Suven apart from its competitors is its strong focus on innovation and commitment to R&D. Moreover, the company's strategic partnerships with multinational pharmaceutical giants have further strengthened its position in the industry. Additionally,